ASN-002 (Ascend Biopharmaceuticals)

N/A

Report date: 2024/04/11 10:47:55

Base Information

Drug NameASN-002 (Ascend Biopharmaceuticals)
Drug Alias NameAdenovirus interferon gamma (Ascend Biopharmaceuticals)human adenovirus 5 vector encoding Interferon-γ (Ascend Biopharmaceuticals)Adenovirus-interferon-γ (Ascend Biopharmaceuticals)TG-1042Ad-IFNγ +[6] 
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionIFN-γ gene transference
TargetsInterferon gamma
Therapy Area/IndicationsSkin MelanomaSolid tumoursSkin Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaSwitzerland +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTransgene Sa
China Registration ClassN/A

Develop Information

Active CompaniesAscend Biopharmaceuticals LtdStamford Pharmaceuticals Inc
Inactive CompaniesTransgene SaUniversity Of Rochester
Active IndicationsCarcinoma, Basal CellBasal Cell Nevus Syndrome
Inactive IndicationsSkin MelanomaSolid tumoursSkin Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A